INTRODUCTION
============

Biological clocks are internal mechanisms that control the periodicity of various biological functions that exist in virtually every life form at every level: single molecules to cells, tissues and organs (for review, cf. [@B001]). These clock rhythms have time scales that vary between milliseconds to second cycles (ultradian), light and dark cycles (circadian) to longer than 24-h cycles (infradian) commensurate with their regulated functions. Thus, under normal physiological states, a system of clocks within cells throughout the body creates a highly integrated network of coupled oscillators with a broad range of frequencies to retain sufficient plasticity in response to environmental stimulation. In mammals, the master clocks are located within the brain and broadcast signals to all tissues [@B002]. Specifically, the circadian clock that orchestrates the circadian activity of the entire body is located in the hypothalamic suprachiasmatic nucleus (SCN).

The brain hierarchical clock system modulates heart rate and rhythm via neurotransmitter release from the vagal and sympathetic nerves to the sinoatrial node (SAN), the heart's primary pacemaker, and activates receptors on the pacemaker cell. These receptors activate different internal mechanisms in pacemaker cells. However, the heart has the ability not only to respond to external stimuli, but also possesses internal chemical and electrical clocks within its pacemaker cells [@B003]. Even without external stimuli from the brain to the heart, ultradian rhythms are maintained in the cardiac interval of mammals, including humans (for extensive reviews, see [@B004], [@B005]). For example, ultradian rhythms exist in 1) patients following heart transplants (i.e., denervated heart), although there is a shift in their frequency behavior [@B006]; 2) isolated hearts (i.e., when the heart is completely detached from both hormonal and neural input) from mammals, including humans [@B007]; 3) monolayers of cultured cells with pacemaker-like activity [@B008]; and 4) isolated rabbit pacemaker cells [@B007], [@B009]-[@B011]. It has recently been discovered how internal clock mechanisms control the heart rate and ultradian rhythm [@B011]. The relative role of these mechanisms in the regulation of circadian rhythms is not known. Our review summarizes the evidence that intrinsic pacemaker cell mechanisms are the end effector of the hierarchical circadian clock system.

THE HEART'S PACEMAKER AS PART OF THE CIRCADIAN SYSTEM
=====================================================

Circadian regulation contributes to normal heart function. For example, certain genes within cardiac cells (e.g., KCNA5, KCND2, KCNK3, KCHIP2) are essential for circadian rhythmic expression in mammals [@B012], [@B013], including humans [@B014]. Disruption of such genes in mice leads to cardiac pathology that includes a reduction in average heart rate, increased beating rate variability, and arrhythmias [@B015]. For example, loss of Scn5a circadian gene expression has been documented in mice with cardiomyocyte-specific deletion of Bmal1 [@B016]. Recent evidence suggests that circadian variations within the heart are not only due to autonomic modulation but are also due to intrinsic mechanisms within the heart's pacemaker cells. R-R (the peak of the ventricle activation, QRS complex, of the ECG signal) intervals of patients with transplanted hearts (i.e., the brain-heart signaling via autonomic nerves is not intact) exhibit circadian rhythms [@B017]. However, in these patients the heart rate is higher and the circadian rhythm variation is lower than in hearts with intact autonomic input [@B018]. Similarly, ablation of the sympathetic and parasympathetic inputs in mice disrupts circadian expression of ion channels, but the daily rhythmicity of clock genes within the heart tissue is not completely eliminated [@B012]. Finally, in the isolated working rat heart (i.e., the brain-heart signaling via autonomic nerves is not intact), there are circadian variations in metabolic flux and contractile function [@B019]: "Contractile performance (i.e., cardiac power), carbohydrate oxidation, and oxygen consumption achieve their maxima in the middle of night".

**Mini summary**

1.  \* Circadian genes are expressed in the heart.

2.  \* Disturbances in circadian gene regulation affect heart rate and rhythm.

3.  \* Circadian variations exist even without nervous system modulation.

INTERACTIONS BETWEEN CARDIAC AUTONOMIC FUNCTION TO CARDIAC PACEMAKER CELLS AND CIRCADIAN RHYTHM
===============================================================================================

The brain hierarchical clock system modulates heart rate and rhythm via neurotransmitter release from the parasympathetic and sympathetic nerves to the SAN [@B020]. Sympathetic or parasympathetic receptor stimulation increases or decreases, respectively, the rate at which nodal cells produce action potentials (APs) [@B021], [@B022]. The level of sympathetic-parasympathetic tone modulates the level of post-translational modification of intrinsic pacemaker cell proteins that drives the coupled-clock mechanism: sympathetic stimulation increases and cholinergic stimulation reduces phosphorylation of proteins that drive coupled-clock molecular functions (i.e., ion channels and Ca^2+^ pumping to the sarcoplasmic reticulum (SR)) [@B022], [@B023]. The activities of L-type Ca^2+^ channels, ryanodine channels and the SR-Ca^2+^ pump determine the AP firing rate (for review, cf [@B003]). Because these mechanism activities are controlled by phosphorylation protein level, the kinetics and stoichiometry of this post-translational protein modification, therefore, can affect the rate and rhythm of spontaneous APs [@B024]. Changes in the sympathetic-parasympathetic tone affect ultradian rhythmic variations: sympathetic stimulation in single pacemaker cell not only markedly decreases the average AP beating interval, but also decreases the ultradian variation indices [@B010], [@B025]. Parasympathetic stimulation, in contrast, not only markedly increases both the average AP beating interval and ultradian AP beating interval variation indices of single isolated pacemaker cells, but also impairs beating interval complexity [@B009], [@B010], [@B026]. Changes in the sympathetic-parasympathetic tone also affect circadian rhythmic variations in mammals including humans [@B027]. Experimental induction of different circadian patterns in humans (shift in the sleep-to-awake transition) demonstrated that "sleep-to-wake transitions occurring in the morning were associated with maximal shifts toward sympathetic autonomic activation compared to those occurring during the rest of the day" [@B028]. Moreover, in both young and aged humans the sympathetic-parasympathetic tone itself is subject to ultradian and circadian rhythmic variations, as evidenced by circadian changes in plasma catecholamine concentrations [@B029]. In a group of healthy young men, both plasma epinephrine and norepinephrine peaked at similar times. Specifically it was demonstrated that "epinephrine levels had no direct relationship to upright posture or rest when awake, whereas norepinephrine levels were significantly higher during upright posture and higher when the subjects were awake than when asleep" [@B030]. If one of the inputs (i.e., autonomic nervous modulation) to the sinoatrial node system possesses rhythmic behavior, it is not surprising that, by responding to the brain's hierarchical clock signals, or to endogenous molecular clock signals, the sinus node rate *in vivo* has a circadian rhythm [@B031] as well as infradian and ultradian rhythms (for review, cf.[@B004]) ([Fig. 1](#F001){ref-type="fig"}).

![The heart beat is controlled by a hierarchical clock system (brain-heart) that synchronizes functions of cells within the sinoatrial node (SAN). The circadian system that orchestrates the circadian activity of the entire body is located in the suprachiasmatic nucleus (SCN). The master clock in the SCN, through its anatomical connection with the preautonomic motor neurons in the paraventricular nucleus of the hypothalamus (HyP), transmits signals to the parasympathetic and sympathetic nervous system enforcing its endogenous rhythmicity to the heart and other organs. Different sensory mechanisms (purple line) detect the SCN signaling in the lung and heart: carotid body (CB) chemical receptors, high-pressure baroreceptors (HPBR) and low-pressure baroreceptors (LPBR). Changes in the levels of hormonal influences such as atrial-natriuretic peptides (ANP), and mechanical factors such as atrial pressure are correlated with changes in circadian rhythms. Both the sympathetic and parasympathetic nervous systems innervate the sinoatrial node (red and green lines). The brain hierarchical clock system modulates heart rate and rhythm via neurotransmitter release from the vagal and sympathetic nerves to the SAN. Vagal nerve stimulates cholinergic receptors on the cell membrane (Ch-R) by acetylcholine (ACH), and sympathetic nerve stimulates adrenergic receptor (β-AR) also located on the cell membrane by norepinephrine (NE). Even in the absence of neuronal input via receptor stimulation, protein phosphorylation, driven by Ca^2+^ activation of calmodulin-adenylyl cyclase (AC)-dependent protein kinase A (PKA) and Ca^2+^/calmodulin-dependent protein kinase II (CaMKII) drives cardiac pacemaker sarcoplasmic reticulum (SR) Ca^2+^ cycling proteins (phospholamban (PLB) interacting with sarcoplasmic reticulum Ca^2+^-ATPase (SERCA), ryanodine receptor (RyR)) and surface membrane ion channels (K^+^ current (I~k~), funny current (I~f~), Na^+^-Ca^2+^ exchanger (NCX) and L-type current (I~Ca~)). Phosphodiesterase (PDE) degrades cAMP and phosphatase (PPT) removes phosphate.](BMB-48-677-g001){#F001}

**Mini summary**

1.  \* Both extrinsic and intrinsic mechanisms determine the heart rate.

2.  \* Intrinsic and extrinsic mechanisms crosstalk through protein phosphorylation.

3.  \* Changes in the sympathetic-parasympathetic tone affect circadian rhythmic variations.

OTHER INPUTS TO PACEMAKER CELLS THAT MEDIATE THE CIRCADIAN RHYTHM
=================================================================

Even when the brain-heart signaling via autonomic nervous system is not intact, internal signaling expresses circadian variation, for example: 1) Changes in the levels of hormonal influences such atrial-natriuretic and brain-natriuretic peptides [@B032] are correlated with changes in heart circadian rhythms. Specifically, "correlations between heart circadian rhythm and changes in mRNAs encoding atrial-natriuretic and brain-natriuretic peptides" have been documented in mice [@B032]; 2) circadian variations in mechanical factors may be implicated circadian variation of heart rate. For example, in humans, the circadian pattern of heart rate is correlated with that of atrial pressure [@B033]. Because these hormonal and mechanical mechanisms exist in the denervated or isolated heart, they may also participate in diurnal variations in the heart *in vivo* ([Fig. 1](#F001){ref-type="fig"}). In parallel to these mechanisms, it is well established that cardiac impulse initiation and conduction involve intracellular Ca^2+^ and surface membrane electrogenic clocks that are coupled by chemical reactions within cardiac pacemaker cells [@B034] (for extensive review, see [@B035]). In the following part of the review, we summarize the evidence that the heart's pacemaker cells are part of the body's circadian system.

**Mini summary**

1.  \* Extrinsic mechanisms other than a neural input affect the heart rate and rhythm.

2.  \* Hormonal and mechanical factors exhibit circadian rhythms.

MECHANISMS INTRINSIC TO PACEMAKER CELLS THAT MEDIATE THE CIRCADIAN RHYTHM
=========================================================================

The cardiac pacemaker can be viewed as a series of biological clocks. The interactions among these ultradian clock functions generate spontaneous action potentials (APs). The Ca^2+^ clock composed of the sarcoplasmic reticulum (SR) that generates local spontaneous ryanodine receptor activation resulting in local diastolic Ca^2+^ releases that activate an inward Na^+^-Ca^2+^ exchanger current [@B023]. The Na^+^-Ca^2+^ exchanger current, the f-channel current, another member of the ensemble of sarcolemmal electrogenic molecule ensemble ("membrane clock"), and inactivation of K^+^ channels concurrently drive the diastolic membrane depolarization to ignite the next AP. Changes in the membrane potential trigger of activation and inactivation of ionic channels that affect the intracellular Ca^2+^ balance and consequently the bound Ca^2+^ to the myofilament and therefore force production. ATP is consumed to maintain these ultradian clock functions. As described above, the ultradian rhythm of heart pacemaker cells is controlled by these coupled-clock mechanisms intrinsic to pacemaker cells and their modulation by autonomic receptor stimulation [@B010], [@B011]. It has recently been shown that the ultradian rhythms of heart rate also exhibit circadian variation. Specifically, in healthy subjects the ratio of low frequency (LF) to high frequency (HF) [@B036] and HF [@B037] are greater during the day than at night (in free-running conditions). Moreover, in mammals, including humans, a fractal structure (i.e., self similarity of internal components) of heart rate fluctuations is embedded within the circadian rhythm [@B038]. Therefore, it is tempting to speculate that the same intrinsic coupled-clock mechanisms that control the ultradian rhythms can also regulate circadian rhythms.

Even in the absence of neuronal input via receptor stimulation, protein phosphorylation, driven by Ca^2+^ activation of calmodulin-adenylyl cyclase (AC)-dependent protein kinase A (PKA) [@B039], [@B040] and Ca^2+^/calmodulin-dependent protein kinase II (CaMKII) drives biophysical mechanisms that couple these clocks to regulate spontaneous AP generation ([Fig. 1](#F001){ref-type="fig"}). In chick retinal cones, CaMKII activity [@B041], similar to other key cardiac signaling molecules in embryonic chick hearts, including Erk, p38, Akt, and GSK-3β [@B042], exhibits circadian variation. Because post-translational protein modification kinetics determine the kinetics of the spontaneous AP firing rate, circadian variation of post-translational protein modification kinetics may play a role in the circadian and ultradian rhythms of the cardiac intervals. Future experiments are required to determine whether post-translational protein modification kinetics exhibit circadian rhythms in pacemaker cells similar to those documented in other organs.

Intracellular Ca^2+^ signaling has been implicated as a key messenger that links the core clock mechanism in SCN neurons to physiological downstream circadian oscillations [@B043], [@B044]. Specifically, cytosolic Ca^2+^ and L-type Ca^2+^ current in mammalian SCN neurons are marked by diurnal and circadian fluctuations [@B045], [@B046]: "L-type Ca^2+^ current displays a larger amplitude when the cytosolic Ca^2+^ increases during the day than the night". Similarly, circadian patterns of regulation of Ca^2+^ channel subunits, Ca^2+^ current densities in embryonic chick hearts [@B042], and K^+^ channel subunit gene expression [@B047] have been identified in rat hearts. Note that because these experiments were performed *in vivo*, both intrinsic mechanisms of pacemaker cells and their modulation by the autonomic nervous system can influence the gene circadian patterns. Future research is required to determine whether the beating interval of pacemaker cells exhibits circadian variation linked to circadian variation in intracellular Ca^2+^, the rate of local Ca^2+^ release and other coupled-clock functions, and the contribution of these, to circadian variation of heart rate. Note also that circadian patterns in intracellular Ca^2+^, in turn, in heart pacemaker cells can affect the kinetics of posttranslational protein modification that determine the kinetics of spontaneous AP firing rate (see above).

**Mini summary**

1.  \* Both Ca^2+^ and the membrane clock mechanisms crosstalk through phosphorylation.

2.  \* Both Ca^2+^ and the membrane clocks determine the heart rate and ultradian rhythms.

3.  \* Future work needs to determine if intrinsic coupled-clock mechanisms that control the ultradian rhythms can also regulate circadian rhythms.

4.  \* Future experiments are required to determine whether spontaneous AP, Ca^2+^ cycling and post-translational protein modification kinetics exhibit circadian rhythms in pacemaker cells.

CIRCADIAN CLOCKS AND ENERGETIC REGULATION
=========================================

There is a circadian pattern of metabolic activity in the rat SCN [@B048]. For example, "glycolysis-related energy pathway activity of SCN is higher during the day than at night" [@B048]. In the heart's pacemaker cells, ATP production by the mitochondria, rather than glycolysis, is largely responsible for maintaining the basal spontaneous AP firing rate [@B049]. Nevertheless, similar to glycolysis, the mitochondrial ATP production exhibits circadian rhythms and the mitochondria can behave as individual pacemakers whose dynamics obey collective network features [@B050]. When the expression of the circadian clock gene CLOCK is altered in the heart, the response of the heart to fatty acid, triglyceride and glycogen metabolism is altered [@B051]. Because ATP supply matches ATP demand on a beat-to-beat basis in the heart [@B052], generation of ATP with circadian variation may be influenced by and influence the rate and rhythm of ATP consumption. Specifically, future work will have to investigate whether the energy balance of the heart, which is controlled by the key ATP consumer, the sarcomere [@B053], exhibits circadian rhythms.

In heart pacemaker cells, in addition to regulation of pacemaker AP firing rate, intracellular Ca^2+^ and Ca^2+^ activation of cAMP/PKA-CaMKII signaling are the core mechanisms that link utilization of ATP and mitochondrial ATP production [@B054], [@B055]. SCN cell cultures from rat, in fact, "exhibit robust rhythms in ATP accumulation that are inversely related to the circadian variation in Ca^2+^" [@B056]. Future experiments in cardiac pacemaker cells are required to verify whether circadian rhythms of the core control mechanisms that link utilization of ATP to the mitochondrial ATP production can maintain circadian rhythms of pacemaker cell activity.

**Mini summary**

1.  \* ATP supply to demand balance in pacemaker cell is controlled by cAMP/PKA and CaMKII signaling.

2.  \* ATP level is correlated with spontaneous AP firing rate, and therefore with ultradian rhythms.

3.  \* Future work needs to determine if mitochondrial ATP production exhibits circadian rhythms.

CIRCADIAN CLOCK ALTERATIONS IN HEART DISEASES AND IN AGING
==========================================================

Elevated heart rate [@B057] and decreased heart rate variability (i.e. ultradian heart rate rhythm) [@B058] are both predictors of increased cardiovascular morbidity and mortality. Because of the links between circadian and ultradian rhythms in the heart (see above), it is not surprising that altered circadian rhythms predict increased cardiovascular morbidity and mortality in humans [@B059]. Specifically, increased circadian rhythm variability is associated with carotid stenosis and increases in all measures of coronary atherogenesis [@B059]. Moreover, cardiac disease event occurrence exhibits circadian variation. For example, "different cardiac diseases (coronary ischemic events, acute myocardial infarction and sudden cardiac death) in males appear to peak during transition from sleep, when the cardiac beating interval and the heart rate variability are reduced" [@B060].

Changes in the properties of coupled-clock mechanisms intrinsic to pacemaker cells that comprise the sinoatrial node and their impaired response to autonomic receptor stimulation have also been implicated in the changes in ultradian rhythms observed in heart diseases [@B005], [@B061]. One can speculate, therefore, that changes in the properties of coupled-clock mechanisms intrinsic to pacemaker cells may also contribute to the changes of circadian rhythm observed in heart diseases.

Patients with chronic heart failure have a higher heart rate and reduced ultradian rhythm compared to healthy subjects [@B062]: Normal circadian rhythms in the ratio of LF to HF do not occur [@B063]. Because of an increase in sympathetic and a decrease in parasympathetic activity in heart failure patients [@B064], it has been assumed that a modification in the autonomic nervous impulse to pacemaker cells is the major reason for changes in ultradian and circadian rhythms. However, changes in intrinsic mechanisms in pacemaker cells have also been documented in pacemaker cells from chronic heart failure rabbits: "The spontaneous AP firing rate in isolated pacemaker cells of rabbits with heart failure is reduced compared to control [@B065]. Moreover, membrane ionic channel remodeling of pacemaker cells accompanies heart failure [@B065]". These results indicate that intrinsic clock mechanisms in the pacemaker cells reduce the heart rate and over-compensation by autonomic nervous impulses to reverse this effect leads to an increase in heart rate *in vivo*.

"In older persons, while circadian variation of heart rate variability is still maintained, the day/night differences are smaller compared to those of younger persons" [@B066]. A parallel reduction in ultradian rhythm has been documented in advanced age [@B067]. Although a reduction in the ratio of parasympathetic to sympathetic tone accompanies advancing age (review in [@B068]), the age-associated decrease in circadian variation of heart rate variability may, in part, be associated with changes in intrinsic intracellular coupled-clock mechanisms that accompany advanced age. It has been shown recently that advanced age in mice is associated with deficient intrinsic cAMP-PKA-Ca^2+^ signaling of sinoatrial node pacemaker cells [@B069]. Future direct measurements comparing circadian clock rhythms in isolated pacemaker cells from control, heart failure and aged mammals are required to determine whether a reduction in the coupling of intrinsic clock mechanisms is also implicated in disturbances in ultradian and circadian rhythms that have been observed in older persons and in heart failure patients.

**Mini summary**

1.  \* Deteriorations of intrinsic and extrinsic mechanisms affect the aged-dependent heart rate.

2.  \* Altered circadian rhythms predict increased cardiovascular morbidity and mortality in humans.

3.  \* Reduction in circadian rhythms accompanies advancing age

SUMMARY
=======

In summary, during health and cardiac disease, cardiovascular function is regulated by the rhythmicity of circadian, infradian and ultradian clocks. The ultradian heart rhythm is determined by properties of clocks intrinsic to cardiac pacemaker cells and modulation by the competing influences of the two branches of their autonomic neural input. Virtually no information exists on how core circadian clock gene products interact with the molecular pathways downstream of adrenergic and muscarinic cholinergic receptors in pacemaker cells. The extent to which ultradian clocks regulation of intrinsic SAN cell mechanisms contribute to circadian variations in heart rate awaits further elucidation. This knowledge will contribute greatly to our understanding of cardiac impulse initiation and the specific role of less well understood circadian signaling in pacemaker regulation in health, in aging and in cardiac disease. Because both intrinsic and extrinsic signaling determine circadian and ultradian rhythms, it is impossible to put ones finger on specific mechanism that is involved only in specific rhythm.
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